about
CD9 moleculeProtein kinase C, deltaSerpin family E member 2ADAM metallopeptidase with thrombospondin type 1 motif 18Protein kinase cGMP-dependent 1SH2B adaptor protein 3Ubiquitin associated and SH3 domain containing B4-aminobutyrate aminotransferaseArachidonate 12-lipoxygenase, 12S typeCEA cell adhesion molecule 1Fibrinogen gamma chainC1q and TNF related 1CD9 antigenArachidonate 12-lipoxygenaseProtein kinase, cGMP-dependent, type IFibrinogen gamma chain4-aminobutyrate aminotransferaseCarcinoembryonic antigen-related cell adhesion molecule 1A disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 18C1q and tumor necrosis factor related protein 1Serine (or cysteine) peptidase inhibitor, clade E, member 2Prostaglandin E2 receptor EP3 subtypeSH2B adaptor protein 3Ubiquitin associated and SH3 domain containing, BCD9 moleculeCEA cell adhesion molecule 1Prostaglandin E receptor 3Fibrinogen gamma chainProtein kinase C, deltaUbiquitin associated and SH3 domain containing, BC1q and TNF related 1Arachidonate 12-lipoxygenase, 12S-typeProtein kinase C delta
P682
IRAG mediates NO/cGMP-dependent inhibition of platelet aggregation and thrombus formationAnticoagulant and antithrombotic properties of platelet protease nexin-1C-terminal ADAMTS-18 fragment induces oxidative platelet fragmentation, dissolves platelet aggregates, and protects against carotid artery occlusion and cerebral strokeC1qTNF-related protein-1 (CTRP-1): a vascular wall protein that inhibits collagen-induced platelet aggregation by blocking VWF binding to collagenLNK/SH2B3 Loss of Function Promotes Atherosclerosis and Thrombosis.Fps/Fes and Fer non-receptor protein-tyrosine kinases regulate collagen- and ADP-induced platelet aggregation.
P921
Q1058190-ADB6D256-BA71-4737-A08E-A82B7443C15BQ15329459-8BEDFB67-E706-4971-8B73-330E351FCFA5Q21101258-317B811F-BAC1-4B6B-A12D-1FB1619D9337Q21105357-71A00033-A4C6-476A-917C-0F77398F1B91Q21106714-CEDD32CC-78B4-41B0-B804-604EA6E64933Q21110148-311CD91F-ADCB-412B-BEE0-1467B84B65BCQ21115617-701FBA73-8C91-4FE2-B4C0-0AC46E3313BCQ21118182-00DFD29F-F6CA-421F-A1C4-4FCFFD05E7FAQ21133173-4FEB921F-662D-4807-BD62-58D2EF26EA39Q21171950-98684A5F-6A23-4D68-977A-B2289FDA4F79Q21172240-A10A3145-FB9C-4A71-9611-92D784C03031Q21173163-A31C9367-E8BD-41FC-A69F-498D56F2E98FQ21494054-BA53E733-6D02-481A-9DEA-6A0A80734D02Q21494714-66A61709-284A-4EE4-A965-15230ED535D9Q21495417-BA6BF5C0-3B10-4A35-A9A6-6AC4FD1F49C3Q21498432-5B3AC812-8087-4ACA-8C52-CAD4496EF1AFQ21498502-B8314047-36B0-478A-BA4A-677892B21B66Q21498502-C7F31AB0-1ADF-4A1F-9277-5911068D51FAQ21499241-54CB3FCE-3ABF-41B3-84DA-4AC034D1E307Q21982992-EDB4F859-FBF3-469F-AD87-BC51B6984D86Q21983610-3F2094ED-5EB8-4A9F-8DC3-ECB6AC8E77A6Q21985382-60157A5A-8989-42A8-9242-B92154D1DB29Q21987842-D6F0810F-F056-42C8-973E-0784C44B259EQ21991444-2C05827C-EA6E-4652-9F5C-5B994BD7C098Q21991945-078CABE2-1B3B-41CE-BE34-07880A51E927Q28556634-EBF18A26-7299-44B5-902B-DBA224B7BCCDQ28557389-16307350-D2A6-40A6-97DF-CF96ACD443DDQ28559745-D7495A8F-8B6F-42EE-B8DD-1913779E0987Q28561266-123C2897-6BC2-4EA5-8095-97827E99A1E0Q28561692-05BDB200-DCE7-4434-84FC-60D9048BE639Q29525177-BAB1AB5A-8EB4-46C5-B14A-DF10789CE149Q55198541-33E04197-4ABC-44F3-9441-BE96ED3D94DBQ55199743-F50F759E-222D-4789-8EFB-9D54A8393D7EQ7120338-F64E8675-31EE-4413-8301-5EEDD9139A0B
P682
description
Any process that decreases the ...... telets via adhesion molecules.
@en
biologisch proces
@nl
name
negative regulation of platelet aggregation
@en
type
label
negative regulation of platelet aggregation
@en
altLabel
GO:0090331
@en
prefLabel
negative regulation of platelet aggregation
@en
P279
P279
P2888
P686
GO:0090331